indazoles has been researched along with rifampin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garrett, M; Hee, B; Klamerus, KJ; Kuruganti, U; Ni, G; Pithavala, YK; Toh, M; Tortorici, M | 1 |
| Adhikari, C; Krishna, VS; Reshma, RS; Sharada, DS; Sriram, D; Vidyacharan, S | 1 |
| Chen, EC; Chen, Y; Choo, EF; Liu, L; Ma, F; Mao, J; Sahasranaman, S; Zhu, R | 1 |
1 trial(s) available for indazoles and rifampin
| Article | Year |
|---|---|
Effect of rifampin on the pharmacokinetics of Axitinib (AG-013736) in Japanese and Caucasian healthy volunteers.
Topics: Adult; Area Under Curve; Asian People; Axitinib; Cross-Over Studies; Cytochrome P-450 CYP3A; Enzyme Inhibitors; Genotype; Glucuronosyltransferase; Humans; Imidazoles; Indazoles; Japan; Male; Metabolic Clearance Rate; Middle Aged; Rifampin; White People; Young Adult | 2010 |
2 other study(ies) available for indazoles and rifampin
| Article | Year |
|---|---|
A robust synthesis of functionalized 2H-indazoles via solid state melt reaction (SSMR) and their anti-tubercular activity.
Topics: Antitubercular Agents; Ciprofloxacin; Ethambutol; Indazoles; Isoniazid; Mycobacterium tuberculosis; Rifampin; Structure-Activity Relationship | 2017 |
Assessment of OATP transporter-mediated drug-drug interaction using physiologically-based pharmacokinetic (PBPK) modeling - a case example.
Topics: Area Under Curve; Cinnamates; Cyclosporine; Drug Interactions; Gemfibrozil; Humans; Indazoles; Liver-Specific Organic Anion Transporter 1; Models, Biological; Pravastatin; Rifampin; Solute Carrier Organic Anion Transporter Family Member 1B3 | 2018 |